Is a complete OTLK research report available?

No complete published report is available for Outlook Therapeutics, Inc. (OTLK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · USD

$0.45

-0.01 (-1.1%)· Recorded snapshot

Market cap	110.7M
Revenue (ttm)	-1.2M
Net income (ttm)	-61.1M
EPS (ttm)	-$0.75
Shares out	243.4M
Volume	2,568,289
Beta	0.67

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -1.2M
Net income (ttm): -61.1M
EPS (ttm): -$0.75
Market cap: 110.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001649989
Company name	Outlook Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	69012T305
Earnings date	2026-12-18
Earnings time	bmo
Employees	17
Employees change	-6
Employees growth	-26.09%
Enterprise value	$117.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2010
Industry	Biotechnology
IPO date	2016-05-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US69012T3059
Last 10-K release date	2025-12-19
Last earnings date	2026-08-14
Last refreshed	2026-11-04
Last stock split date	2024-03-14
Last stock split type	Reverse
Market cap	$110.7M
Market cap category	Micro-Cap
Next earnings date	2026-12-18
Options	Yes
Price	$0.45
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-11-04
Symbol	OTLK
U.S. state	New Jersey
Website	https://outlooktherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001649989

Company name

Outlook Therapeutics, Inc.

Country

United States

Country code

CUSIP number

69012T305

Earnings date

2026-12-18

Earnings time

bmo

Employees

Employees change

-6

Employees growth

-26.09%

Enterprise value

$117.9M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

September

Founded

2010

Industry

Biotechnology

IPO date

2016-05-13

Is primary listing

Yes

Is SPAC

ISIN number

US69012T3059

Last 10-K release date

2025-12-19

Last earnings date

2026-08-14

Last refreshed

2026-11-04

Last stock split date

2024-03-14

Last stock split type

Reverse

Market cap

$110.7M

Market cap category

Micro-Cap

Next earnings date

2026-12-18

Options

Yes

Price

$0.45

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-11-04

Symbol

OTLK

U.S. state

New Jersey

Website

https://outlooktherapeutics.com

Metric	Value
Earnings yield	-164.42%
FCF / EV yield	-46.79%
FCF yield	-49.78%
Forward EV/Sales	4.35x
Forward P/S	4.09x
Sector forward P/E	24x
Sector P/E	49.18x

Metric

Value

Earnings yield

-164.42%

FCF / EV yield

-46.79%

FCF yield

-49.78%

Forward EV/Sales

4.35x

Forward P/S

4.09x

Sector forward P/E

24x

Sector P/E

49.18x

Metric	Value
Operating margin	4,781.84%
Pretax margin	5,387.1%
Profit per employee	$-3.6M
ROA	-143.17%
ROA (5Y)	-147.64%
ROCE	2,230.6%
ROIC	-1,253.84%
SBC / revenue	-365.36%

Metric

Value

Operating margin

4,781.84%

Pretax margin

5,387.1%

Profit per employee

$-3.6M

ROA

-143.17%

ROA (5Y)

-147.64%

ROCE

2,230.6%

ROIC

-1,253.84%

SBC / revenue

-365.36%

Metric	Value
EPS growth quarters	2
EPS growth years	10
Net income growth years	1
Revenue growth (Q)	-99.42%
Revenue growth (QoQ)	-93.17%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth (Q)

-99.42%

Revenue growth (QoQ)

-93.17%

Revenue growth years

Metric	Value
Depreciation and amortization	$104,019
EBIT	$-55.6M
EBITDA	$-55.5M
EPS	$-0.75
FCF per share	$-0.23
Financing cash flow	$60.6M
Free cash flow	$-56.2M
Free cash flow minus SBC	$-60.4M
Gross profit	$-2.3M
Income taxes	$-1.6M
Investing cash flow	$-2.1M
Net borrowing	$-2.3M
Net cash flow	$2.3M
Net income	$-61.1M
Operating cash flow minus SBC	$-60.4M
Operating income	$-55.6M
Revenue	$-1.2M
Stock-based compensation	$4.3M

Metric

Value

Depreciation and amortization

$104,019

EBIT

$-55.6M

EBITDA

$-55.5M

EPS

$-0.75

FCF per share

$-0.23

Financing cash flow

$60.6M

Free cash flow

$-56.2M

Free cash flow minus SBC

$-60.4M

Gross profit

$-2.3M

Income taxes

$-1.6M

Investing cash flow

$-2.1M

Net borrowing

$-2.3M

Net cash flow

$2.3M

Net income

$-61.1M

Operating cash flow minus SBC

$-60.4M

Operating income

$-55.6M

Revenue

$-1.2M

Stock-based compensation

$4.3M

Metric	Value
Altman Z-Score	-41.12
Book value per share	$-0.06
Interest coverage	-210.62
Long-term assets	$3M
Long-term liabilities	$7.9M
Net cash (debt)	$-7.2M
Net cash / market cap	-6.37%
Piotroski F-Score	3
Property, plant and equipment	$185,183
Shareholders' equity	$-10.4M
Tangible book value	$-10.4M
Tangible book value per share	$-0.06
Total assets	$26.2M
Total cash	$11.2M
Total debt	$18.4M
Total liabilities	$36.6M
WACC	7%

Metric

Value

Altman Z-Score

-41.12

Book value per share

$-0.06

Interest coverage

-210.62

Long-term assets

$3M

Long-term liabilities

$7.9M

Net cash (debt)

$-7.2M

Net cash / market cap

-6.37%

Piotroski F-Score

Property, plant and equipment

$185,183

Shareholders' equity

$-10.4M

Tangible book value

$-10.4M

Tangible book value per share

$-0.06

Total assets

$26.2M

Total cash

$11.2M

Total debt

$18.4M

Total liabilities

$36.6M

WACC

Metric	Value
Current assets	$23.2M
Current liabilities	$28.7M
Current ratio	0.81
Inventory turnover	0.24
Net working capital	$1.5M
Quick ratio	0.45
Working capital	$-5.5M
Working capital turnover	0.15

Metric

Value

Current assets

$23.2M

Current liabilities

$28.7M

Current ratio

0.81

Inventory turnover

0.24

Net working capital

$1.5M

Quick ratio

0.45

Working capital

$-5.5M

Working capital turnover

0.15

Metric	Value
Buyback yield / dilution	-182.49%
Dividend yield	0%
Shareholder yield	-182.49%

Metric

Value

Buyback yield / dilution

-182.49%

Dividend yield

Shareholder yield

-182.49%

Metric	Value
10Y price change	-99.93%
10Y return CAGR	-51.55%
10Y total return	-99.93%
150-day SMA	$0.75
1D price change	-1.11%
1M price change	-23.56%
1M total return	-23.56%
1W price change	-16.81%
1W total return	-16.81%
1Y price change	-65.13%
1Y return CAGR	-65.16%
1Y total return	-65.13%
20-day SMA	$0.52
200-day SMA	$0.66
3M price change	-50.35%
3M total return	-50.35%
3Y price change	-94.7%
3Y return CAGR	-62.42%
3Y total return	-94.7%
50-day SMA	$0.59
50-day SMA vs 200-day SMA	50under200
52-week high	$2.54
52-week high date	2025-12-17
52-week low	$0.16
52-week low date	2026-03-24
5Y price change	-98.94%
5Y return CAGR	-59.7%
5Y total return	-98.94%
6M price change	72.88%
6M total return	72.88%
After-hours change	1.96%
After-hours close	$0.46
After-hours price	$0.47
All-time high	$878.40
All-time high date	2016-09-01
All-time low	$0.16
All-time low date	2026-03-24
Average true range (ATR)	$0.05
Average volume	3.7M
Beta (1Y)	3.39
Beta (2Y)	1.83
Beta (5Y)	0.67
Change from 52-week high	-82.08%
Change from 52-week low	182.37%
Change from all-time high	-99.95%
Change from all-time low	181.38%
Change from open	-1%
Day's gap	-0.11%
Dollar volume	$1.2M
High price	$0.48
Low price	$0.44
Monthly RSI	36.86
Open price	$0.46
Position in 52-week range	30.72%
Premarket change	0%
Premarket close	$0.46
Premarket price	$0.46
Previous close	$0.46
Price vs 150-day SMA	-39.59%
Price vs 20-day SMA	-12.49%
Price vs 200-day SMA	-31.49%
Price vs 50-day SMA	-23.12%
Relative volume	0.69
RSI	34.39
Sharpe ratio	0.1
Sharpe ratio (3Y)	-0.09
Sharpe ratio (5Y)	-0.03
Sortino ratio	0.19
Sortino ratio (3Y)	-0.09
Sortino ratio (5Y)	0.01
Volume	2.6M
Weekly RSI	39.18
YTD price change	-71.31%
YTD total return	-71.31%

Metric

Value

10Y price change

-99.93%

10Y return CAGR

-51.55%

10Y total return

-99.93%

150-day SMA

$0.75

1D price change

-1.11%

1M price change

-23.56%

1M total return

-23.56%

1W price change

-16.81%

1W total return

-16.81%

1Y price change

-65.13%

1Y return CAGR

-65.16%

1Y total return

-65.13%

20-day SMA

$0.52

200-day SMA

$0.66

3M price change

-50.35%

3M total return

-50.35%

3Y price change

-94.7%

3Y return CAGR

-62.42%

3Y total return

-94.7%

50-day SMA

$0.59

50-day SMA vs 200-day SMA

50under200

52-week high

$2.54

52-week high date

2025-12-17

52-week low

$0.16

52-week low date

2026-03-24

5Y price change

-98.94%

5Y return CAGR

-59.7%

5Y total return

-98.94%

6M price change

72.88%

6M total return

72.88%

After-hours change

1.96%

After-hours close

$0.46

After-hours price

$0.47

All-time high

$878.40

All-time high date

2016-09-01

All-time low

$0.16

All-time low date

2026-03-24

Average true range (ATR)

$0.05

Average volume

3.7M

Beta (1Y)

3.39

Beta (2Y)

1.83

Beta (5Y)

0.67

Change from 52-week high

-82.08%

Change from 52-week low

182.37%

Change from all-time high

-99.95%

Change from all-time low

181.38%

Change from open

-1%

Day's gap

-0.11%

Dollar volume

$1.2M

High price

$0.48

Low price

$0.44

Monthly RSI

36.86

Open price

$0.46

Position in 52-week range

30.72%

Premarket change

Premarket close

$0.46

Premarket price

$0.46

Previous close

$0.46

Price vs 150-day SMA

-39.59%

Price vs 20-day SMA

-12.49%

Price vs 200-day SMA

-31.49%

Price vs 50-day SMA

-23.12%

Relative volume

0.69

RSI

34.39

Sharpe ratio

0.1

Sharpe ratio (3Y)

-0.09

Sharpe ratio (5Y)

-0.03

Sortino ratio

0.19

Sortino ratio (3Y)

-0.09

Sortino ratio (5Y)

0.01

Volume

2.6M

Weekly RSI

39.18

YTD price change

-71.31%

YTD total return

-71.31%

Metric	Value
Float	176.6M
Float percentage	72.53%
Shares change (QoQ)	67.09%
Shares change (YoY)	182.49%
Shares held by insiders	0.42%
Shares held by institutions	21.43%
Shares outstanding	243.4M
Short % of float	18.46%
Short % of shares	13.39%
Short ratio	7 days

Metric

Value

Float

176.6M

Float percentage

72.53%

Shares change (QoQ)

67.09%

Shares change (YoY)

182.49%

Shares held by insiders

0.42%

Shares held by institutions

21.43%

Shares outstanding

243.4M

Short % of float

18.46%

Short % of shares

13.39%

Short ratio

7 days

Outlook Therapeutics, Inc. (OTLK)

Price

Financial snapshot

Fair-value bridge

Latest news · OTLK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OTLK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OTLK

Frequently asked questions